PTEN and Familial prostate cancer: In conclusion, we show here that high miRs-17, -20a, -106a and -106b expression is strongly correlated with prostate cancer progression, and confirm PTEN tumor suppressor as a key target of these oncomiRs in prostate cancer cells.